MN
Therapeutic Areas
ACM Biolabs Pipeline
| Drug | Indication | Phase |
|---|---|---|
| mRNA Rabies Vaccine | Rabies (infectious disease) | Preclinical |
| CpG Oligonucleotide Oncology | Solid Tumor (cold tumors) | Phase 1 |
Leadership Team at ACM Biolabs
PV
Pierre Vandepapelière
Clinical Advisor
EE
Erich Erber
Director of the Board
SB
Sang Bin Ong
Director of the Board
MH
Maria Halasz
Director of the Board
DK
Dennis Klinman
Scientific Advisor
PM
Peter Moran
Corporate Affairs
KS
Katherine Schultheis
Head of Discovery Research
FQ
Fong Qiwei
Finance and Administration Manager